Emerging Company Profile
SciNeuro reunites GSK R&D vets to bring CNS therapies to China
Emerging Company Profile: SciNeuro to build neurodegeneration, neuropsychiatric pipeline via partnering, in-house R&D
Founder and CEO Min Li discusses the company’s partnering and R&D strategy.
Jan 22, 2021 | 1:19 AM GMT
Led by GSK neuro R&D alumni